4DMT Reports Third Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
Completed enrollment and randomization of the 4FRONT-2 Global Phase 3 clinical trial, the second of
Completed enrollment and randomization of the 4FRONT-2 Global Phase 3 clinical trial, the second of